Gan & Lee Pharmaceuticals. (SHA:603087)
65.75
-0.35 (-0.53%)
At close: Feb 6, 2026
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 39.13 billion as of February 6, 2026. Its market cap has increased by 59.90% in one year.
Market Cap
39.13B
Enterprise Value
35.97B
Revenue
3.85B
Ranking
n/a
PE Ratio
41.78
Stock Price
65.75
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 39.13B, an increase of 7.01%. That is a compound annual growth rate of 1.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 39.13B | -3.41% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imeik Technology Development | 45.34B |
| Intco Medical Technology | 26.81B |
| iRay Group | 25.78B |
| Winner Medical | 20.89B |
| Zhende Medical | 19.49B |
| Andon Health | 17.65B |
| Shenyang Xingqi Pharmaceutical | 17.10B |
| Micro-Tech (Nanjing) Co.,Ltd | 15.15B |